Immatics (IMTX) Short-term Investments (2019 - 2025)
Immatics (IMTX) posted Short-term Investments of $143.7 million for Q4 2025, up 28.12% sequentially from $112.1 million in Q3 2025, and down 63.44% YoY from $392.9 million in Q4 2024.
Immatics (IMTX) Short-term Investments (2019 - 2025) Analysis & Trends
Immatics has reported Short-term Investments for 7 years, with the latest figure at $143.7 million in Q4 2025.
- Quarterly Short-term Investments fell 63.44% year-over-year to $143.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $143.7 million (down 63.44% YoY) and the FY2025 annual result came in at $139.4 million, down 64.96% from the prior year.
- Short-term Investments grew to $143.7 million in Q4 2025 per IMTX's latest filing, from $112.1 million in the prior quarter.
- Over five years, Short-term Investments peaked at $480.0 million in Q1 2024 and troughed at $6.1 million in Q1 2022.
- A 5-year average of $196.8 million and a median of $220.6 million in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments slumped 76.31% in 2022, then jumped 3633.3% in 2023.
- Over 5 years, Short-term Investments stood at $13.9 million in 2021, then soared by 1472.01% to $218.0 million in 2022, then grew by 2.37% to $223.2 million in 2023, then jumped by 76.06% to $392.9 million in 2024, then slumped by 63.44% to $143.7 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $143.7 million, $112.1 million, and $250.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 143.67 Mn |
| Sep 30, 2025 | 112.13 Mn |
| Jun 30, 2025 | 250.79 Mn |
| Mar 31, 2025 | 316.53 Mn |
| Dec 31, 2024 | 392.93 Mn |
| Sep 30, 2024 | 330.92 Mn |
| Jun 30, 2024 | 401.64 Mn |
| Mar 31, 2024 | 480.02 Mn |
| Dec 31, 2023 | 223.17 Mn |
| Sep 30, 2023 | 307.61 Mn |
| Jun 30, 2023 | 236.54 Mn |
| Mar 31, 2023 | 227.43 Mn |
| Dec 31, 2022 | 218.01 Mn |
| Sep 30, 2022 | 132.37 Mn |
| Jun 30, 2022 | 63.23 Mn |
| Mar 31, 2022 | 6.09 Mn |
| Dec 31, 2021 | 13.87 Mn |
| Sep 30, 2021 | 14.06 Mn |
| Jun 30, 2021 | 39.39 Mn |
| Mar 31, 2021 | 25.72 Mn |